Target intelligence / Profile preview

Invertebrate glycine receptor (GlyR) (GlyR)

Target
GlyR
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor
01

Overview

Invertebrate glycine receptors (GlyRs) are members of the Cys-loop superfamily of ligand-gated ion channels that mediate fast inhibitory neurotransmission in various non-vertebrate species, including nematodes, insects, and mollusks (Jones & Sattelle, 2008). These receptors function as chloride-selective channels that, upon binding glycine, induce membrane hyperpolarization, thereby reducing neuronal excitability and muscle contraction (McCracken et al., 2010). While they share structural homology with vertebrate GlyRs, invertebrate versions often exhibit distinct pharmacological sensitivities; for instance, some are less sensitive to the classical antagonist strychnine but are highly sensitive to macrocyclic lactones like ivermectin (Lynagh & Lynch, 2012). In organisms like Caenorhabditis elegans, these receptors are encoded by genes such as glc-1, glc-2, and glc-3, and they play vital roles in regulating locomotion and pharyngeal pumping. Because of their essential role in parasite physiology and their divergence from human receptor subtypes, they serve as critical targets for anthelmintic and insecticidal drugs used in human medicine, veterinary care, and agriculture.

Other names
Invertebrate glycine-gated chloride channelGlycine-activated chloride channelGLC-1GLC-2GLC-3GLC-4Cys-loop ligand-gated ion channel
02

Mechanism of action

Agonism or positive allosteric modulation of the chloride channel, leading to an influx of chloride ions, hyperpolarization of the postsynaptic membrane, and subsequent inhibition of neuromuscular activity.

03

Biological functions

Inhibitory neurotransmissionLocomotionNeuromuscular coordinationSensory processingPharyngeal pumping
04

Disease associations

HelminthiasisParasitic infectionAgricultural pest infestation
05

Safety considerations

Potential neurotoxicity in hosts with compromised blood-brain barriers (e.g., MDR1-deficient dogs) due to interaction with vertebrate GABA-A or Glycine receptorsDevelopment of multi-drug resistance in target parasite populationsEnvironmental toxicity to non-target aquatic and terrestrial invertebrates
06

Interacting drugs

Ivermectin

5 more in the full profile.

07

Biomarkers

glc-1 gene mutationsglc-2 expression levelsSingle nucleotide polymorphisms (SNPs) associated with macrocyclic lactone resistance

Beyond the preview

Go deeper on Invertebrate glycine receptor (GlyR) (GlyR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invertebrate glycine receptor (GlyR) (GlyR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call